Prevalence of type 2 diabetes mellitus in patients with chronic kidney disease in nizhnii novgorog region


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. Assessment of prevalence of diabetes mellitus (DM) type 2 in patients with chronic kidney disease (CKD) in Nizhnii Novgorod region. Methods. 1051 CKD patients, consulted in Regional clinical hospital and City of Nizhnii Novgorod center of nephrology in 2008-20і3, were included into the study. Results of clinical and laboratory investigation were submitted into the Nizhnii Novgorod CKD registry. Results. dm type 2 is і5,6 % among all the causes of CKD in Nizhnii Novgorod region. 72 % of all patients with dm had CKd stage 2. Microalbuminuria was found mostly often after 5 years, proteinuria - after 10 years after dm manifestation. Conclusion. Diabetes mellitus type 2 is one of the leading causes of chronic kidney disease in Nizhnii Novgorog region

Full Text

Restricted Access

References

  1. Дедов И.И., Шестакова М.В. Сахарный диабет: диагностика, лечение, профилактика. - М.: ООО «Медицинское информационное агентство». - 2011. - C. 94-95.
  2. Donnelly R., Emslie-Smith A.M. Vascular complication of diabetes // BMJ. - 2000. - Vol. 15(320). - P. 1062-1066.
  3. Маслова О.В., Сунцов Ю.И., Шестакова М.В. и др. Распространенность поражения почек при сахарном диабете 1 и 2 типов в Российской Федерации // Сахарный диабет. - 2009. - № 4. - С. 48-51.
  4. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease //Am. J. Kidney Dis. - 2007. - Vol. 49 (Suppl. 2). - P. 1-180.
  5. Шестакова М.В. Современное понятие «Хроническая болезнь почек»: методы диагностики, клиническое значение// Сахарный диабет. - 2008. - № 2. - С. 4-7.
  6. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification // Am. J. Kidney Dis. - 2002. - Vol. 39. - P. 1-286.
  7. Шестакова М.В. Сахарный диабет и хроническая болезнь почек: современная диагностика и лечение// Вестник РАМН. - 2012. - № 1. - С. 45-49.
  8. Шестакова М.В., Дедов И.И. Сахарный диабет и хроническая болезнь почек. - М.: ООО «Медицинское информационное агентство». - 2009. - С. 15-30.
  9. Cederholm J., Eliasson B. et al. For the steering committee of the Swedish National Diabetes Register. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients // Diabetes Research and Clinical Practice. - 2005. - Vol. 67. - P. 258-266.
  10. Parving H.-H., Lewis J.B. et al. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global prespective // Kidney Int. - 2006. - Vol. 69(11). - P. 2057-2063.
  11. Jermendy G., Ruggenenti P. Preventing microalbuminuria in patients with type 2 diabetes// Diabetes/Metabolism. - 2007. - Vol. 23(2). - P. 100-110.
  12. Viberti, G. Regression of albuminuria: latest evidence for a new approach // J. Hypertens. - 2003. - Vol. 21. - P. 24-28.
  13. The Diabetes Control and Complications Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes control and Complications Trial// Kidney Int. - 1995. - Vol. 47. - P. 1703-1720.
  14. Дедов И.И., Шестакова М.В. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. - М. - 2013. - C. 45-52.
  15. Pierrat A., Gravier E., Saunders C. et al. Predicting GFR in children and adults: a comparison of the Cockcroft-Gault, Schwartz and Modification of Diet in Renal Disease formulas // Kidney Int. - 2003. - Vol. 64. - P. 1425-1436.
  16. Vervoort G., Willems H.L., Wetzels J.F. Assessment of glomerular filtration rate in healthy subjects and and normoalbuminuric diabetic patients: validity of a new (MDRD)prediction equation//Nephrol. Dial. Transplant. - 2002. - Vol. 17. - P. 1909-1913

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies